Bank Of New York Mellon Corp Allovir, Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$0.64 - $0.78 $29,152 - $35,529	-45,551 Reduced 22.22%	159,423 $120 Million
Q4 2023 Jan 29, 2024	BUY	$0.68 - $2.39 $25,325 - $89,010	37,243 Added 22.2%	204,974 $139 Million
Q3 2023 Oct 24, 2023	BUY	$2.15 - $3.64 $28,446 - $48,160	13,231 Added 8.56%	167,731 $361 Million
Q2 2023 Aug 03, 2023	BUY	$3.17 - $5.82 $115,746 - $212,505	36,513 Added 30.95%	154,500 $525 Million
Q1 2023 May 09, 2023	BUY	$3.94 - $7.05 $464,868 - $831,808	117,987 New	117,987 $465 Million
Q4 2022 Feb 14, 2023	BUY	$4.7 - $9.98 $514,006 - $1.09 Million	109,363 New	109,363 $561,000
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $67,232 - $143,092	16,279 Added 17.48%	109,423 $862,000
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $16,485 - $35,702	5,057 Added 5.74%	93,144 $364,000
Q4 2021 Feb 11, 2022	SELL	$12.94 - $25.99 $129 - $259	-10 Reduced 0.01%	88,087 $1.14 Million
Q3 2021 Nov 12, 2021	BUY	$16.97 - $25.06 $221,017 - $326,381	13,024 Added 17.35%	88,097 $2.21 Million
Q2 2021 Aug 11, 2021	SELL	$19.44 - $25.06 $176,670 - $227,745	-9,088 Reduced 10.8%	75,073 $1.48 Million
Q1 2021 May 13, 2021	BUY	$20.81 - $45.5 $345,113 - $754,572	16,584 Added 24.54%	84,161 $1.97 Million
Q4 2020 Feb 09, 2021	BUY	$23.94 - $46.81 $356,059 - $696,205	14,873 Added 28.22%	67,577 $2.6 Million
Q3 2020 Nov 12, 2020	BUY	$21.05 - $42.7 $1.11 Million - $2.25 Million	52,704 New	52,704 $1.45 Million

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $51.2M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.